The best injections for weight loss that are FDA-approved and can be administered at home are Wegovy, Saxenda, and Zepbound. Current studies indicate that Wegovy and Zepbound provide the best results.
FDA-Approved Weight Loss Injections
The FDA has approved three injectable medications for weight loss:
| Medication | Administration | Efficacy |
|---|---|---|
| Wegovy | Once-weekly subcutaneous injection | Shows optimal results according to a 2022 study |
| Saxenda | Daily subcutaneous injection | Effective but generally less impactful than Wegovy and Zepbound |
| Zepbound | Once-weekly subcutaneous injection | Shows optimal results, comparable to Wegovy |
Wegovy
- Wegovy is a once-weekly injectable medication.
- A 2022 study indicated it produces the best results for weight loss compared to a placebo or other diabetes medications.
- It is designed to be used along with a reduced-calorie diet and increased physical activity.
Saxenda
- Saxenda is a daily injectable medication.
- While effective, studies suggest it may not provide as much weight loss as Wegovy or Zepbound.
- It is also meant to be used in conjunction with diet and exercise.
Zepbound
- Zepbound is also a once-weekly injectable medication.
- It has shown optimal results, comparable to Wegovy in studies.
- Like Wegovy and Saxenda, it is used along with a reduced-calorie diet and increased physical activity.
Considerations
- Consult a doctor: It is essential to consult with a healthcare provider before starting any weight loss medication. They can help determine the best option based on your medical history and specific needs.
- Proper use: These medications are prescribed by a healthcare professional and instructions for self-administration must be carefully followed to ensure safety and effectiveness.
- Lifestyle changes: These medications are most effective when combined with a reduced-calorie diet and increased physical activity.
In conclusion, while all three medications are approved for weight loss, Wegovy and Zepbound stand out as the most effective options for at-home use based on current studies.
